Home › Companies › BIO-RAD LABORATORIES INC. › 2023-2024
Compiled from SEC Form N-PX filings and BIO-RAD LABORATORIES INC.’s Form 8-K, filed 2024-04-26 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore BIO-RAD LABORATORIES INC. in the interactive database Compare manager voting policies
These tallies are BIO-RAD LABORATORIES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-04-26 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Melinda Litherland | 17,178,561 | 2,491,017 | 8,267 | -- | 1,944,423 | Majority: yes |
| Elect Director: Arnold A. Pinkston | 17,412,897 | 2,255,866 | 9,082 | -- | 1,944,423 | Majority: yes |
| Elect Director: Jeffrey L. Edwards | 4,992,038 | 325 | 1 | -- | 51,564 | Majority: yes |
| Elect Director: Gregory K. Hinckley | 4,991,949 | 325 | 90 | -- | 51,564 | Majority: yes |
| Elect Director: Allison Schwartz | 4,990,900 | 1,374 | 90 | -- | 51,564 | Majority: yes |
| Elect Director: Norman Schwartz | 4,990,900 | 1,374 | 90 | -- | 51,564 | Majority: yes |
Source: BIO-RAD LABORATORIES INC., Form 8-K, filed with the SEC on 2024-04-26 — read the filing on EDGAR.
Each item below shows how the 133 asset managers that disclosed a BIO-RAD LABORATORIES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIO-RAD LABORATORIES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
BIO-RAD LABORATORIES INC.’s own tally for this item (“Elect Director: Arnold A. Pinkston”): 17,412,897 for, 2,255,866 against, per its Form 8-K filed 2024-04-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,518,000 outstanding shares: 61% for, 8% against (69% of the company cast a for/against vote).
The 126 asset managers below cast 88% of the shares they voted on this item FOR (5,614,850 for, 761,498 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,317,903 | 0 | 0 | 0 | For |
| Fidelity | 493,070 | 106,808 | 0 | 0 | For |
| BlackRock | 523,514 | 247 | 0 | 0 | For |
| Invesco | 392,972 | 0 | 0 | 0 | For |
| Parnassus | 0 | 237,790 | 0 | 0 | Against |
| LONGLEAF PARTNERS FUNDS TRUST | 233,124 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 217,933 | 0 | 0 | Against |
| State Street | 206,861 | 11 | 0 | 0 | For |
| Dimensional | 184,559 | 0 | 0 | 0 | For |
| Transamerica | 145,513 | 0 | 0 | 0 | For |
| Allspring | 130,904 | 0 | 0 | 0 | For |
| Putnam | 0 | 102,198 | 0 | 0 | Against |
| Investment Managers Series Trust III | 80,868 | 0 | 0 | 0 | For |
| John Hancock | 79,914 | 0 | 0 | 0 | For |
| Artisan | 62,582 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 58,914 | 0 | 0 | 0 | For |
| TIAA | 58,459 | 0 | 0 | 0 | For |
| Brighthouse | 41,077 | 325 | 721 | 0 | For |
| Gabelli | 41,550 | 0 | 0 | 0 | For |
| Equitable | 27,914 | 12,343 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,713 | 0 | 0 | 0 | For |
| Mercer Funds | 35,425 | 0 | 0 | 0 | For |
| Virtus | 35,376 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 34,010 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 33,013 | 0 | 0 | 0 | For |
Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
BIO-RAD LABORATORIES INC.’s own tally for this item (“Elect Director: Melinda Litherland”): 17,178,561 for, 2,491,017 against, per its Form 8-K filed 2024-04-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,518,000 outstanding shares: 60% for, 9% against (69% of the company cast a for/against vote).
The 126 asset managers below cast 85% of the shares they voted on this item FOR (5,412,659 for, 963,689 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,317,903 | 0 | 0 | 0 | For |
| Fidelity | 493,070 | 106,808 | 0 | 0 | For |
| BlackRock | 523,514 | 247 | 0 | 0 | For |
| Invesco | 392,972 | 0 | 0 | 0 | For |
| Parnassus | 0 | 237,790 | 0 | 0 | Against |
| LONGLEAF PARTNERS FUNDS TRUST | 233,124 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 217,933 | 0 | 0 | Against |
| State Street | 206,861 | 11 | 0 | 0 | For |
| Dimensional | 0 | 184,559 | 0 | 0 | Against |
| Transamerica | 145,513 | 0 | 0 | 0 | For |
| Allspring | 130,904 | 0 | 0 | 0 | For |
| Putnam | 0 | 102,198 | 0 | 0 | Against |
| Investment Managers Series Trust III | 80,868 | 0 | 0 | 0 | For |
| John Hancock | 65,924 | 13,990 | 0 | 0 | For |
| Artisan | 62,582 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 58,914 | 0 | 0 | 0 | For |
| TIAA | 58,459 | 0 | 0 | 0 | For |
| Brighthouse | 41,077 | 325 | 721 | 0 | For |
| Gabelli | 41,550 | 0 | 0 | 0 | For |
| Equitable | 27,914 | 12,343 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,713 | 0 | 0 | 0 | For |
| Mercer Funds | 35,425 | 0 | 0 | 0 | For |
| Virtus | 35,376 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 34,010 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 33,013 | 0 | 0 | 0 | For |
Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.7% fund support · no official result
The 124 asset managers below cast 99.7% of the shares they voted on this item FOR (6,333,056 for, 18,634 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,317,903 | 0 | 0 | 0 | For |
| Fidelity | 599,878 | 0 | 0 | 0 | For |
| BlackRock | 523,761 | 0 | 0 | 0 | For |
| Invesco | 392,972 | 0 | 0 | 0 | For |
| Parnassus | 237,790 | 0 | 0 | 0 | For |
| LONGLEAF PARTNERS FUNDS TRUST | 233,124 | 0 | 0 | 0 | For |
| Charles Schwab | 217,933 | 0 | 0 | 0 | For |
| State Street | 206,870 | 2 | 0 | 0 | For |
| Dimensional | 184,559 | 0 | 0 | 0 | For |
| Transamerica | 145,513 | 0 | 0 | 0 | For |
| Allspring | 130,904 | 0 | 0 | 0 | For |
| Putnam | 102,198 | 0 | 0 | 0 | For |
| Investment Managers Series Trust III | 80,868 | 0 | 0 | 0 | For |
| John Hancock | 79,914 | 0 | 0 | 0 | For |
| Artisan | 62,582 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 58,914 | 0 | 0 | 0 | For |
| TIAA | 58,459 | 0 | 0 | 0 | For |
| Brighthouse | 41,798 | 0 | 0 | 0 | For |
| Gabelli | 41,700 | 0 | 0 | 0 | For |
| Equitable | 40,257 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,564 | 149 | 0 | 0 | For |
| Mercer Funds | 35,425 | 0 | 0 | 0 | For |
| Virtus | 35,376 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 34,010 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 33,013 | 0 | 0 | 0 | For |
Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% fund support · no official result
The 122 asset managers below cast 99.9% of the shares they voted on this item FOR (6,347,644 for, 4,397 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,317,903 | 0 | 0 | 0 | For |
| Fidelity | 599,878 | 0 | 0 | 0 | For |
| BlackRock | 523,761 | 0 | 0 | 0 | For |
| Invesco | 392,972 | 0 | 0 | 0 | For |
| Parnassus | 237,790 | 0 | 0 | 0 | For |
| LONGLEAF PARTNERS FUNDS TRUST | 233,124 | 0 | 0 | 0 | For |
| Charles Schwab | 217,933 | 0 | 0 | 0 | For |
| State Street | 206,870 | 2 | 0 | 0 | For |
| Dimensional | 184,559 | 0 | 0 | 0 | For |
| Transamerica | 145,513 | 0 | 0 | 0 | For |
| Allspring | 130,904 | 0 | 0 | 0 | For |
| Putnam | 102,198 | 0 | 0 | 0 | For |
| Investment Managers Series Trust III | 80,868 | 0 | 0 | 0 | For |
| John Hancock | 79,914 | 0 | 0 | 0 | For |
| Artisan | 62,582 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 58,914 | 0 | 0 | 0 | For |
| TIAA | 58,459 | 0 | 0 | 0 | For |
| Brighthouse | 41,077 | 0 | 721 | 0 | For |
| Gabelli | 41,700 | 0 | 0 | 0 | For |
| Equitable | 40,257 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,713 | 0 | 0 | 0 | For |
| Mercer Funds | 35,425 | 0 | 0 | 0 | For |
| Virtus | 35,376 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 34,010 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 33,013 | 0 | 0 | 0 | For |
Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.
100% fund support · no official result
The 6 asset managers below cast 100% of the shares they voted on this item FOR (47,051 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SECTOR GAMMA AS | 22,835 | 0 | 0 | 0 | For |
| Empower | 15,667 | 0 | 0 | 0 | For |
| Aspiration Funds | 8,057 | 0 | 0 | 0 | For |
| Brighthouse | 325 | 0 | 0 | 0 | For |
| Symmetry Panoramic Trust | 108 | 0 | 114 | 0 | Abstain |
| Regime de rentes du Mouvement Desjardins | 59 | 0 | 0 | 0 | For |
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (24,157 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 15,667 | 0 | 0 | 0 | For |
| Aspiration Funds | 8,057 | 0 | 0 | 0 | For |
| Brighthouse | 325 | 0 | 0 | 0 | For |
| Symmetry Panoramic Trust | 108 | 0 | 114 | 0 | Abstain |
Ranked by the number of BIO-RAD LABORATORIES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 28,518,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.13% |
| 2 | Fidelity | 2.10% |
| 3 | BlackRock | 1.84% |
| 4 | Invesco | 1.38% |
| 5 | Parnassus | 0.83% |
| 6 | LONGLEAF PARTNERS FUNDS TRUST | 0.82% |
| 7 | Charles Schwab | 0.76% |
| 8 | State Street | 0.73% |
| 9 | Dimensional | 0.65% |
| 10 | Transamerica | 0.51% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 6.29% | 13F |
| BlackRock | 5.95% | 13F |
| State Street | 3.06% | 13F |
| Geode Capital | 1.66% | 13F |
| Invesco | 1.62% | 13F |
| Dimensional Fund Advisors | 1.06% | 13F |
| Northern Trust | 0.89% | 13F |
| Norges Bank | 0.79% | 13F |
| Charles Schwab | 0.78% | 13F |
| Morgan Stanley | 0.61% | 13F |
Percentages above are of 28,518,000 shares outstanding, as reported by BIO-RAD LABORATORIES INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-RAD LABORATORIES INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At BIO-RAD LABORATORIES INC.'s shareholder meeting held 2024-04-23, in the 2023-2024 proxy season, 133 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,095 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Nominees: Arnold A. Pinkston — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIO-RAD LABORATORIES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-04-26.
BIO-RAD LABORATORIES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.